Atlas Trials

Pilot Study of the Safety and Efficacy of Sulfasalazine in Pulmonary Arterial Hypertension

Clinical trial NCT04528056 · UNKNOWN

Trial details

NCT number
NCT04528056
Sponsor
RenJi Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2020-08-01
Primary completion
2021-12-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.